ArticleNature communications2024

CAR-T cell therapy targeting surface expression of TYRP1 to treat cutaneous and rare melanoma subtypes.

Sameeha Jilani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.